Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.

DEP Presentation at Radiopharmaceuticals Summit

Results of 2024 Reconvened Annual General Meeting

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Starpharma Holdings (SPL AU)

DEP Presentation at Radiopharmaceuticals Summit

Results of 2024 Reconvened Annual General Meeting

AGM Notice of Reconvened Meeting

Results of 2024 Annual General Meeting

AGM Chair's address and CEO's presentation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)